Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性，不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.lungcan.2024.107992
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0169500224005269
其他信息:
出版社: Elsevier BV
作者: Yuki Kato; Hibiki Udagawa; Shingo Matsumoto; Hiroki Izumi; Yuichiro Ohe; Terufumi Kato; Kazumi Nishino; Shingo Miyamoto; Sachiko Kawana; Kenichi Chikamori; Masato Shingyoji; Yuki Sato; Yuji Takada; Ryo Toyozawa; Koichi Azuma; Yu Tanaka; Tetsuya Sakai; Yuji Shibata; Eri Sugiyama; Kaname Nosaki; Yoshitaka Zenke; Shigeki Umemura; Kiyotaka Yoh; Masahiro Seike; Koichi Goto
